|
|
|
Insider
Information: |
Galakatos Nicholas |
Relationship: |
Director, 10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
24,434 |
|
Indirect Shares
|
17,952,130 |
|
|
Direct
Value |
$227,089 |
|
|
Indirect Value
|
$86,682,240 |
|
|
Total
Shares |
17,976,564 |
|
|
Total
Value |
$86,909,329 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
6
|
Stock
price went up :
|
0
|
6
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
0.0%
|
44.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2004-07-02 |
0 |
2004-07-02 |
1,833,597 |
Premium* |
|
Affymax Inc |
AFFY |
Director, 10% Owner |
2006-12-20 |
18,750 |
2006-12-20 |
1,600,469 |
Premium* |
|
Ithaka Acquisition Corp |
ITHKU |
10% Owner |
|
0 |
2007-06-21 |
2,672,568 |
Premium* |
|
American Cryostem Corporation |
CRYO |
10% Owner |
2007-04-24 |
0 |
2008-05-28 |
0 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
Director |
2010-03-17 |
0 |
2010-03-17 |
2,208,961 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-06-10 |
0 |
2014-06-10 |
1,220,672 |
Premium* |
|
Nanostring Technologies Inc |
NSTG |
Director, 10% Owner |
2013-07-01 |
0 |
2018-09-17 |
4,036,025 |
Premium* |
|
Iveric Bio Inc |
ISEE |
Director |
2016-01-11 |
5,684 |
2016-01-11 |
3,945 |
Premium* |
|
Astria Therapeutics, Inc |
ATXS |
Director, 10% Owner |
2015-06-30 |
0 |
2015-06-30 |
2,752,488 |
Premium* |
|
Entasis Therapeutics Holdings Inc. |
ETTX |
Director, 10% Owner |
2018-09-28 |
0 |
2018-09-28 |
1,623,405 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NSTG |
Nanostring Technologies I... |
Director |
|
2018-09-17 |
4 |
OE |
$8.45 |
$1,372,023 |
I/I |
162,408 |
4,121,848 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Director |
|
2018-09-17 |
4 |
S |
$15.99 |
$1,372,310 |
I/I |
(85,823) |
4,036,025 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Director |
|
2013-07-01 |
4 |
A |
$10.00 |
$7,500,000 |
I/I |
750,000 |
3,959,440 |
0 |
- |
|
NSTG |
Nanostring Technologies I... |
Director |
|
2013-07-01 |
4 |
A |
$0.00 |
$0 |
I/I |
3,209,440 |
3,209,440 |
0 |
- |
|
CRYO |
American Cryostem Corpora... |
10% Owner |
|
2007-04-24 |
4 |
B |
$5.14 |
$496,272 |
I/I |
96,551 |
3,028,082 |
1.5 |
- |
|
ISEE |
Iveric Bio Inc |
Director |
|
2014-06-12 |
4 |
S |
$44.51 |
$2,101,657 |
I/I |
(47,217) |
2,796,347 |
0 |
- |
|
ATXS |
Astria Therapeutics, Inc |
Director |
|
2015-06-30 |
4 |
B |
$12.00 |
$4,520,340 |
I/I |
376,695 |
2,752,488 |
2.25 |
- |
|
ISEE |
Iveric Bio Inc |
Director |
|
2014-06-13 |
4 |
S |
$44.01 |
$3,621,225 |
I/I |
(82,277) |
2,714,070 |
0 |
- |
|
ISEE |
Iveric Bio Inc |
Director |
|
2014-06-16 |
4 |
S |
$44.00 |
$681,208 |
I/I |
(15,482) |
2,698,588 |
0 |
- |
|
ITHKU |
Ithaka Acquisition Corp |
10% Owner |
|
2007-06-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,672,568 |
|
- |
|
ATXS |
Astria Therapeutics, Inc |
Director |
|
2015-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,375,793 |
2,375,793 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
Director |
|
2010-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
2,208,961 |
2,208,961 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2013-05-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,441,344 |
2,032,239 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-07-02 |
4 |
S |
$15.33 |
$25,325 |
I/I |
(1,652) |
1,833,597 |
|
- |
|
ETTX |
Entasis Therapeutics Hold... |
Director |
|
2018-09-28 |
4 |
B |
$15.00 |
$6,800,925 |
I/I |
453,395 |
1,623,405 |
2.25 |
- |
|
AFFY |
Affymax Inc |
Director |
|
2006-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,534,898 |
1,600,469 |
0 |
- |
|
ISEE |
Iveric Bio Inc |
Director |
|
2014-06-16 |
4 |
D |
$44.24 |
$50,602,515 |
I/I |
(1,143,844) |
1,554,744 |
0 |
- |
|
ETTX |
Entasis Therapeutics Hold... |
Director |
|
2018-09-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,097,753 |
1,170,010 |
0 |
- |
|
AFFY |
Affymax Inc |
Director |
|
2006-12-19 |
4 |
OE |
$17.00 |
$1,823,522 |
I/I |
107,266 |
138,514 |
0 |
- |
|
AFFY |
Affymax Inc |
Director |
|
2006-12-19 |
4 |
D |
$25.00 |
$1,823,575 |
I/I |
(72,943) |
65,571 |
0 |
- |
|
AFFY |
Affymax Inc |
Director |
|
2006-12-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
31,248 |
|
- |
|
AFFY |
Affymax Inc |
Director |
|
2006-12-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,750 |
|
- |
|
ISEE |
Iveric Bio Inc |
Director |
|
2015-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,319 |
15,204 |
0 |
- |
|
ISEE |
Iveric Bio Inc |
Director |
|
2015-06-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,020 |
14,184 |
0 |
- |
|
ISEE |
Iveric Bio Inc |
Director |
|
2015-11-02 |
4 |
AS |
$54.00 |
$54,000 |
D/D |
(1,000) |
13,184 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|